Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000755884 | SCV000526539 | uncertain significance | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
ARUP Laboratories, |
RCV000755884 | SCV000883529 | uncertain significance | not provided | 2017-09-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000876680 | SCV001019283 | benign | Biotinidase deficiency | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000755884 | SCV001134039 | uncertain significance | not provided | 2019-04-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002521735 | SCV003718401 | likely benign | Inborn genetic diseases | 2022-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000876680 | SCV001460179 | uncertain significance | Biotinidase deficiency | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000755884 | SCV001963498 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000755884 | SCV001965523 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003912709 | SCV004731070 | benign | BTD-related disorder | 2019-05-27 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |